Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

BACKGROUND: Activating mutations of the epidermal growth factor receptor (EGFR) confer sensitivity to the tyrosine kinase inhibitors (TKi), gefitinib and erlotinib. We analysed EGFR expression, EGFR mutation status and gene expression profiles of prostate cancer (PC) to supply a rationale for EGFR t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peraldo-Neia, Caterina, Migliardi, Giorgia, Mello-Grand, Maurizia, Montemurro, Filippo, Segir, Raffaella, Pignochino, Ymera, Cavalloni, Giuliana, Torchio, Bruno, Mosso, Luciano, Chiorino, Giovanna, Aglietta, Massimo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040720/
https://www.ncbi.nlm.nih.gov/pubmed/21266046
http://dx.doi.org/10.1186/1471-2407-11-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040720/
https://www.ncbi.nlm.nih.gov/pubmed/21266046
http://dx.doi.org/10.1186/1471-2407-11-31

Ejemplares similares